lansoprazole has been researched along with Acute Hepatic Failure in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakatake, R | 1 |
| Hishikawa, H | 1 |
| Kotsuka, M | 1 |
| Ishizaki, M | 1 |
| Matsui, K | 1 |
| Nishizawa, M | 1 |
| Yoshizawa, K | 1 |
| Kaibori, M | 1 |
| Okumura, T | 1 |
1 other study available for lansoprazole and Acute Hepatic Failure
| Article | Year |
|---|---|
The Proton Pump Inhibitor Lansoprazole Has Hepatoprotective Effects in In Vitro and In Vivo Rat Models of Acute Liver Injury.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Hepatocytes; Lansoprazole; Liver; Liver Failure, A | 2019 |